Market brief — July 5, 2026

Vendredi, European markets closed with strong gains as the CAC 40 (FR) rose 0.39% to 8,508.07 and the DAX (EU) climbed 0.78% to 25,779.31, while the Euro Stoxx 50 (EU) advanced 0.82% to 6,412.68^[1]. US indices showed a mixed picture: the S&P 500 (US) held flat at 7,483.24, but the Nasdaq (US) slipped 0.8% to 25,832.67^[1]. This divergence stems from a repricing of the rates path following surprise US employment data released Thursday, where non-agricultural job creation in June totaled only 57,000 against a forecast of 110,000, pushing the unemployment rate down to 4.2%^[3]. The macro regime now favors a renewed risk-on stance in European cyclicals, while US tech faces pressure from shifting rate expectations.

The flows suggest a rotation away from crowded tech positions into value and cyclicals, confirmed by a softening dollar and stable credit spreads. European equities are outperforming US peers, indicating a regional de-risking in favor of the Eurozone’s growth outlook. The employment surprise has reinforced expectations for a more dovish Federal Reserve, which is supporting European asset valuations. However, the Nasdaq’s decline signals that high-growth tech remains vulnerable to rate volatility, creating a bifurcated market where defensive and cyclical sectors lead.

Today’s Cash Scanner TOP 10 highlights idiosyncratic momentum in US healthcare and biotech, with PTC Therapeutics Inc (PTCT) scoring 42 and gapping +2.4% on a vortex↑ and KST↑ signal^[1]. Teladoc Inc (TDOC) follows with a score of 40, breaking out over 20 days with rising volume and ADX 37^[1]. US Foods Holding Corp (USFD) also shows strength, scoring 39 with a 20-day breakout and ADX 47^[1]. The sector mix is dominated by healthcare (2×), biotech (1×), and retail (1×), reflecting early signs of a defensive rotation amid tech weakness. These signals align with broader flows favoring non-tech sectors as rates expectations shift.

The coming week’s agenda includes US Q2 GDP preliminary data on Tuesday, which could recalibrate rate expectations, and the ECB’s monetary policy meeting on Thursday, likely to influence Eurozone equities. Friday’s US PCE inflation data will be critical for Fed policy signals. Any surprise in GDP or inflation could trigger volatility in both US and European indices.

Key risks include a potential upside surprise in US inflation, which could reverse dovish rate expectations and pressure equities. A geopolitical escalation in Eastern Europe could disrupt European cyclicals, while a sudden shift in Fed rhetoric could destabilize US tech valuations.

Actionable lines: Consider a long position in PTC Therapeutics Inc (PTCT) above 84.50 with a stop at 82.00, targeting a 5% move on confirmed volume. For the CAC 40, a breakout above 8,550 could signal further European cyclicals strength, while a drop below 8,450 may indicate a reversal. Monitor Teladoc Inc (TDOC) for a continuation of its 20-day breakout above 9.50, with a stop at 8.90.

Bonne journée aux p&l makers.